Terms: = Breast cancer AND SDC4, ENSG00000124145, 6385, P31431, SYND4, MGC22217
17 results:
1. Stiff matrix induced srGAP2 tension gradients control migration direction in triple-negative breast cancer.
Li C; Zheng Z; Wu X; Xie Q; Liu P; Hu Y; Chen M; Liu L; Zhao W; Chen L; Guo J; Song Y
Theranostics; 2023; 13(1):59-76. PubMed ID: 36593959
[No Abstract] [Full Text] [Related]
2. Syndecan-4 regulates the HER2-positive breast cancer cell proliferation cells via CK19/AKT signalling.
Pham SH; Vuorinen SI; Arif KT; Griffiths LR; Okolicsanyi RK; Haupt LM
Biochimie; 2023 Apr; 207():49-61. PubMed ID: 36460206
[TBL] [Abstract] [Full Text] [Related]
3. sdc4-rs1981429, ATM-rs228590 and biomarkers of breast cancer risk.
Mungmunpuntipantip R; Wiwanitkit V
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1657. PubMed ID: 36335555
[TBL] [Abstract] [Full Text] [Related]
4. sdc4-rs1981429 and ATM-rs228590 may provide early biomarkers of breast cancer risk.
Vuorinen SI; Okolicsanyi RK; Gyimesi M; Meyjes-Brown J; Saini D; Pham SH; Griffiths LR; Haupt LM
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4563-4578. PubMed ID: 36152082
[TBL] [Abstract] [Full Text] [Related]
5. Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression.
Beauvais DM; Nelson SE; Adams KM; Stueven NA; Jung O; Rapraeger AC
J Biol Chem; 2022 Jun; 298(6):102029. PubMed ID: 35569509
[TBL] [Abstract] [Full Text] [Related]
6. Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers.
Pham SH; Pratt K; Okolicsanyi RK; Oikari LE; Yu C; Peall IW; Arif KT; Chalmers TA; Gyimesi M; Griffiths LR; Haupt LM
Biochimie; 2022 Jul; 198():60-75. PubMed ID: 35183674
[TBL] [Abstract] [Full Text] [Related]
7. The action of hyaluronan in functional properties, morphology and expression of matrix effectors in mammary cancer cells depends on its molecular size.
Tavianatou AG; Piperigkou Z; Koutsakis C; Barbera C; Beninatto R; Franchi M; Karamanos NK
FEBS J; 2021 Jul; 288(14):4291-4310. PubMed ID: 33512780
[TBL] [Abstract] [Full Text] [Related]
8. Pharmacological inhibition of syntenin PDZ2 domain impairs breast cancer cell activities and exosome loading with syndecan and EpCAM cargo.
Leblanc R; Kashyap R; Barral K; Egea-Jimenez AL; Kovalskyy D; Feracci M; Garcia M; Derviaux C; Betzi S; Ghossoub R; Platonov M; Roche P; Morelli X; Hoffer L; Zimmermann P
J Extracell Vesicles; 2020 Dec; 10(2):e12039. PubMed ID: 33343836
[TBL] [Abstract] [Full Text] [Related]
9. A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism.
Wang L; Collings CK; Zhao Z; Cozzolino KA; Ma Q; Liang K; Marshall SA; Sze CC; Hashizume R; Savas JN; Shilatifard A
Genes Dev; 2017 Oct; 31(20):2056-2066. PubMed ID: 29138278
[TBL] [Abstract] [Full Text] [Related]
10. Association of heparan sulfate proteoglycans SDC1 and sdc4 polymorphisms with breast cancer in an Australian Caucasian population.
Okolicsanyi RK; Buffiere A; Jacinto JM; Chacon-Cortes D; Chambers SK; Youl PH; Haupt LM; Griffiths LR
Tumour Biol; 2015 Mar; 36(3):1731-8. PubMed ID: 25361632
[TBL] [Abstract] [Full Text] [Related]
11. Functional proteomics, human genetics and cancer biology of GIPC family members.
Katoh M
Exp Mol Med; 2013 Jun; 45(6):e26. PubMed ID: 23743496
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells.
Tsonis AI; Afratis N; Gialeli C; Ellina MI; Piperigkou Z; Skandalis SS; Theocharis AD; Tzanakakis GN; Karamanos NK
FEBS J; 2013 May; 280(10):2248-59. PubMed ID: 23374155
[TBL] [Abstract] [Full Text] [Related]
13. Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells.
Ridgway LD; Wetzel MD; Ngo JA; Erdreich-Epstein A; Marchetti D
Mol Cancer Res; 2012 Jun; 10(6):689-702. PubMed ID: 22513363
[TBL] [Abstract] [Full Text] [Related]
14. Syndecan-4 promotes cytokinesis in a phosphorylation-dependent manner.
Keller-Pinter A; Bottka S; Timar J; Kulka J; Katona R; Dux L; Deak F; Szilak L
Cell Mol Life Sci; 2010 Jun; 67(11):1881-94. PubMed ID: 20229236
[TBL] [Abstract] [Full Text] [Related]
15. Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors.
Torrisi R; Dellapasqua S; Ghisini R; Viale G; Veronesi P; Luini A; Intra M; Peruzzotti G; Rocca A; Balduzzi A; Cardillo A; Goldhirsch A; Colleoni M
Breast; 2008 Dec; 17(6):654-60. PubMed ID: 18595702
[TBL] [Abstract] [Full Text] [Related]
16. Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer.
Helle SI; Geisler J; Anker GB; Leirvaag B; Holly JM; Lønning PE
Br J Cancer; 2001 Jul; 85(2):147-51. PubMed ID: 11461068
[TBL] [Abstract] [Full Text] [Related]
17. Comparison of the costs of fine-needle aspiration and open surgical biopsy as methods for obtaining a pathologic diagnosis.
Rimm DL; Stastny JF; Rimm EB; Ayer S; Frable WJ
Cancer; 1997 Feb; 81(1):51-6. PubMed ID: 9100542
[TBL] [Abstract] [Full Text] [Related]
